Biotechnological implications of the salivary proteome

Trends in Biotechnology

Volumn 29, Issue 8, 2011, Pages 409-418

  Castagnola, Massimo ^a,b   Cabras, Tiziana ^c   Vitali, Alberto ^b   Sanna, Maria Teresa ^c   Messana, Irene ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGICAL APPLICATIONS; NOVEL FUNCTIONS; PEPTIDOMIMETICS; POTENTIAL APPLICATIONS; PROTEOMIC ANALYSIS; SALIVARY BIOMARKERS; SALIVARY PROTEINS; SAMPLING PROCEDURES; SYSTEMIC DISEASE; WHOLE SALIVA;

BIOTECHNOLOGY; BODY FLUIDS; PEPTIDES;

DIAGNOSIS;

ALBUMIN; ALPHA DEFENSIN; AMYLASE; BASE; CALCYCLIN; CALGRANULIN A; CALGRANULIN B; CARBONATE DEHYDRATASE IV; COMPLEMENTARY DNA; HISTATIN; LACTOFERRIN; LYSOZYME; MUCIN; PEROXIDASE; PROLINE RICH PROTEIN; PROTEOME; PSORIASIN; SALIVA PROTEIN; SERINE; STATHERIN; STEFIN A; STEFIN B; THYMOSIN; THYMOSIN BETA4;

ACIDITY; ALLELE; BODY FLUID; ELECTROSPRAY; FLOW RATE; GENE LOCUS; HUMAN; MOUTH CAVITY; PAROTID GLAND; PHOSPHORYLATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEOMICS; REVIEW; SALIVA; SALIVARY GLAND;

BIOTECHNOLOGY; HUMANS; PROTEOME; PROTEOMICS; SALIVARY PROTEINS AND PEPTIDES;

EID: 79960345148     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2011.04.002     Document Type: Review

References (79)

1. Dodds M.W., et al. Health benefits of saliva: a review. J. Dent. 2005, 33:223-233.
2. Denny P., et al. The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J. Proteome Res. 2008, 7:1994-2006.
3. Bandhakavi S., et al. A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva. J. Proteome Res. 2009, 8:5590-5600.
4. Messana I., et al. Facts and artifacts in proteomics of body fluids, What proteomics of saliva is telling us?. J. Sep. Sci. 2008, 31:1948-1963.
5. Inzitari R., et al. Different isoforms and post-translational modifications of human salivary acidic proline-rich proteins. Proteomics 2005, 5:805-815.
6. Messana I., et al. Trafficking and postsecretory events responsible for the formation of secreted human salivary peptides: a proteomics approach. Mol. Cell. Proteomics 2008, 7:911-926.
7. Cabras T., et al. Age-dependent modifications of the human salivary secretory protein complex. J. Proteome Res. 2009, 8:4126-4134.
8. Helmerhorst E.J., et al. Identification of Lys-Pro-Gln as a novel cleavage site specificity of saliva-associated proteases. J. Biol. Chem. 2008, 283:19957-19966.
9. Ramachandran P., et al. Comparison of N-linked glycoproteins in human whole saliva, parotid, submandibular, and sublingual glandular secretions identified using hydrazide chemistry and mass spectrometry. Clin. Proteom. 2008, 4:80-104.
10. Brunati A.M., et al. Novel consensus sequence for the Golgi apparatus casein kinase, revealed using proline-rich protein-1 (PRP1)-derived peptide substrates. Biochem. J. 2000, 351:765-768.
11. Morzel E., et al. Saliva electrophoretic protein profiles in infants: changes with age and impact of teeth eruption and diet transition. Arch. Oral Biol. 2011, 10.1016/j.archoralbio.2010.12.015.
12. Castagnola M., et al. The surprising composition of the salivary proteome of preterm human newborn. Mol. Cell. Proteomics 2011, 10. M110.003467.
13. Reti R., et al. Thymosin beta 4 is cytoprotective in human gingival fibroblasts. Eur. J. Oral Sci. 2008, 116:424-430.
14. Inzitari R., et al. HPLC-ESI-MS analysis of oral human fluids reveals that gingival crevicular fluid is the main source of oral thymosins beta(4) and beta(10). J. Sep. Sci. 2009, 32:57-63.
15. Nemolato S., et al. Thymosin beta(4) and beta(10) levels in pre-term newborn oral cavity and foetal salivary glands evidence a switch of secretion during foetal development. PLoS ONE 2009, 4:e5109.
16. Inzitari R., et al. Proteomic analysis of salivary acidic proline-rich proteins in human preterm and at-term newborns. J. Proteome Res. 2007, 6:1371-1377.
17. Lu Y., et al. Interaction of tannin with human salivary proline-rich proteins. Arch. Oral Biol. 1998, 43:717-728.
18. Robinovitch M.R., et al. Parotid salivary basic proline-rich proteins inhibit HIV-1 infectivity. Oral Dis. 2001, 7:86-93.
19. Huang C.M., et al. A peptide with a ProGln C terminus in the human saliva peptidome exerts bactericidal activity against Propionibacterium acnes. Antimicrob. Agents Chemother. 2008, 52:1834-1836.
20. Gorr S.-U. Antimicrobial peptides of the oral cavity. Periodontology 2000 2009, 51:152-180.
21. Castagnola M., et al. A cascade of 24 histatins (histatin 3 fragments) in human saliva, Suggestions for a pre-secretory sequential cleavage pathway. J. Biol. Chem. 2004, 279:41436-41443.
22. van den Bossche H., et al. Biochemical effects of micronazole on fungi II. Inhibition of ergosterol biosynthesis in Candida albicans. Chem. Biol. Interact. 1978, 21:59-78.
23. Helmerhorst E.J., et al. The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J. Biol. Chem. 1999, 274:7286-7291.
24. Jang W.S., et al. Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans. Mol. Microbiol. 2010, 77:354-370.
25. Diaz G., et al. Mitochondrial alterations and autofluorescent conversion of Candida albicans induced by histatins. Microsc. Res. Tech. 2005, 66:219-228.
26. Komatsu T., et al. Influence of histatin 5 on Candida albicans mitochondrial protein expression assessed by quantitative mass spectrometry. J. Proteome Res. 2010, 10.1021/pr100861k.
27. Imamura Y., et al. Cooperation of salivary protein histatin 3 with heat shock cognate protein 70 relative to the G1/S transition in human gingival fibroblasts. J. Biol. Chem. 2009, 284:14316-14325.
28. Oudhoff M.J., et al. Histatins are the major wound closure stimulating factors in human saliva as identified in a cell culture assay. FASEB J. 2008, 22:3805-3812.
29. Oudhoff M.J., et al. Structure-activity analysis of histatin, a potent wound healing peptide from human saliva: cyclization of histatin potentiates molar activity 1,000-fold. FASEB J. 2009, 23:3928-3935.
30. Oudhoff M.J., et al. Histatins enhance wound closure with oral and non-oral cells. J. Dent. Res. 2009, 88:846-850.
31. Schüpbach P., et al. Electron-microscopic demonstration of proline-rich proteins, statherin, and histatins in acquired enamel pellicles in vitro. Eur. J. Oral Sci. 2001, 109:60-68.
32. Raj P.A., et al. Novel molecules for intra-oral delivery of antimicrobials to prevent and treat oral infectious diseases. Biochem. J. 2008, 409:601-609.
33. Mannherz H.G., Hannappel E. The beta-thymosins: intracellular and extracellular activities of a versatile actin binding protein family. Cell. Motil. Cytoskeleton 2009, 66:839-851.
34. Tabak L.A. A revolution in biomedical assessment: the development of salivary diagnostics. J. Dent. Educ. 2001, 65:1335-1339.
35. Loo J.A., et al. Comparative human salivary and plasma proteomes. J. Dent. Res. 2010, 89:1016-1023. (Review).
36. Castagnola M., et al. Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders. J. Proteome Res. 2008, 7:5327-5332.
37. Min G.S., et al. Salivary transcriptome of the North American medicinal leech, Macrobdella decora. J. Parasitol. 2010, 96:1211-1221.
38. Ma D., et al. Anti-thrombosis repertoire of blood-feeding horsefly salivary glands. Mol. Cell Proteomics 2009, 9:2071-2079.
39. Fanali C., et al. Mass spectrometry strategies applied to the characterization of proline-rich peptides from secretory parotid granules of pig (Sus scrofa). J. Sep. Sci. 2008, 31:516-522.
40. Manconi B., et al. Structural characterization of a new statherin from pig parotid granules. J. Pept. Sci. 2010, 16:269-275.
41. Rijnkels M., et al. Multispecies comparative analysis of a mammalian-specific genomic domain encoding secretory proteins. Genomics 2003, 82:417-432.
42. Oppenheim F.G., et al. Salivary proteome and its genetic polymorphisms. Ann. N. Y. Acad. Sci. 2007, 1098:22-50.
43. Campese M., et al. Concentration and fate of histatins and acidic proline-rich proteins in the oral environment. Arch. Oral Biol. 2009, 54:345-353.
44. Kivelä J., et al. A low concentration of carbonic anhydrase isoenzyme VI in whole saliva is associated with caries prevalence. Caries Res. 1999, 33:178-184.
45. Fernley R.T., et al. Radioimmunoassay for salivary carbonic anhydrase in human parotid saliva. Arch. Oral Biol. 1995, 40:567-569.
46. Terrapon B., et al. Salivary albumin of edentulous patients. Arch. Oral Biol. 1996, 41:1183-1185.
47. Gardner M.S., et al. Comprehensive defensin assay for saliva. Anal. Chem. 2009, 81:557-566.
48. Salih E., et al. Large-scale phosphoproteome of human whole saliva using disulfide-thiol interchange covalent chromatography and mass spectrometry. Anal. Biochem. 2010, 407:19-33.
49. Vitorino R., et al. Finding new posttranslational modifications in salivary proline-rich proteins. Proteomics 2010, 10:3732-3742.
50. Azen E.A., et al. PRB1, PRB2, and PRB4 coded polymorphisms among human salivary concanavalin-A binding, II-1, and Po proline-rich proteins. Am. J. Hum. Genet. 1996, 58:143-153.
51. Lyons K.M., et al. Many protein products from a few loci: assignment of human salivary proline-rich proteins to specific loci. Genetics 1988, 120:255-265.
52. Cabras T., et al. Tyrosine polysulfation of human salivary histatin 1 A post-translational modification specific of the submandibular gland. J. Proteome Res. 2007, 6:2472-2480.
53. Helmerhorst E.J., et al. Saliva: a dynamic proteome. J. Dent. Res. 2007, 86:680-693.
54. Chen Y., et al. Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues. Am. J. Respir. Cell. Mol. Biol. 2004, 30:155-165.
55. Ryan C.M., et al. Confident assignment of intact mass tags to human salivary cystatins using top-down Fourier-transform ion cyclotron resonance mass spectrometry. J. Am. Soc. Mass. Spectrom. 2010, 21:908-917.
56. Cabras T., et al. Alterations of the salivary secretory peptidome profile in children affected by type 1 diabetes. Mol. Cell. Proteomics 2010, 9:2099-2108.
57. Hirtz C., et al. MS characterization of multiple forms of alpha-amylase in human saliva. Proteomics 2005, 5:4597-4607.
58. Pisano E., et al. Peptides of human gingival crevicular fluid determined by HPLC-ESI-MS. Eur. J. Oral Sci. 2005, 113:462-468.
59. Hannappel E. beta-Thymosins. Ann. N.Y. Acad. Sci 2007, 1112:21-37.
60. Hannappel E. Thymosin beta4 and its post-translational modifications. Ann. N.Y. Acad. Sci. 2010, 1194:27-35.
61. Jou Y., et al. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal. Chim. Acta 2010, 681:41-48.
62. Shintani S., et al. Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform. Int. J. Oral. Maxillofac. Surg. 2010, 39:68-74.
63. Hu S., et al. Salivary proteomics for oral cancer biomarker discovery. Clin. Cancer Res. 2008, 14:6246-6252.
64. Mizukawa N., et al. Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients. Anticancer Res. 1998, 18:4645-4649.
65. Dowling P., et al. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J. Proteomics 2008, 21:168-175.
66. Ohshiro H., et al. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma. Int. J. Oncol. 2007, 30:743-749.
67. de Jong E.P., et al. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS ONE 2010, 5:e11148.
68. Chen Y.C., et al. Analysis of the saliva from patients with oral cancer by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2002, 16:364-369.
69. Contucci A.M., et al. Statherin levels in saliva of patients with precancerous and cancerous lesions of the oral cavity: a preliminary report. Oral Dis. 2005, 11:95-99.
70. Wu Y., et al. Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. J. Periodontal Res. 2009, 44:636-644.
71. Haigh B.J., et al. Alterations in the salivary proteome associated with periodontitis. J. Clin. Periodontol. 2010, 37:241-247.
72. Vitorino R., et al. Two-dimensional electrophoresis study of in vitro pellicle formation and dental caries susceptibility. Eur. J. Oral Sci. 2006, 114:147-153.
73. Giusti L., et al. Proteome analysis of whole saliva: a new tool for rheumatic diseases: the example of Sjögren's syndrome. Proteomics 2007, 7:1634-1643.
74. Ryu O.H., et al. Identification of parotid salivary biomarkers in Sjögren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology 2006, 45:1077-1086.
75. Peluso G., et al. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum. 2007, 56:2216-2222.
76. Fleissig Y., et al. Different proteomic protein patterns in saliva of Sjögren's syndrome patients. Oral Dis. 2009, 15:61-68.
77. Bazzichi L., et al. Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteomics Clin. Appl. 2009, 3:1296-1304.
78. Giusti L., et al. Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis?. Proteomics Clin. Appl. 2010, 4:315-324.
79. Rao P.V., et al. Proteomic identification of salivary biomarkers of type-2 diabetes. J. Proteome Res. 2009, 8:239-245.